FRANCISCO DE PAULA
TELLEZ PEREZ
Profesor asociado de Ciencias de la Salud
Hospital Universitario de Donostia
San Sebastián, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de Donostia (11)
2021
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
2019
-
Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes
Journal of Hepatology
-
Increasing importance of european lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain
Eurosurveillance, Vol. 24, Núm. 9
-
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 33, Núm. 2, pp. 269-278
-
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
PLoS ONE, Vol. 14, Núm. 8
2018
-
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 32, Núm. 11, pp. 1423-1430
2017
-
Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 31, Núm. 1, pp. 89-95
2015
-
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term
Hepatology, Vol. 61, Núm. 5, pp. 1503-1511
2013
-
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients
AIDS, Vol. 27, Núm. 16, pp. 2541-2549
-
Risk of liver decompensation among HIV/Hepatitis C virus-coinfected individuals with advanced fibrosis: Implications for the timing of therapy
Clinical Infectious Diseases, Vol. 57, Núm. 10, pp. 1401-1408
2011
-
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 6, pp. 1346-1350